直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

European IP Blog

Priority Right Presumption at the EPO

12 October 2023

Authored and Edited by James G. Bell; Maeve O'Flynn; Yelena Morozova

The recent decision in the consolidated cases G1/22 and G2/22 before the Enlarged Board of Appeals effectively redefines the way transfer of the priority right under Article 87 EPC is regarded at the European Patent Office (“EPO”), which affects both patent applicants for and patent opponents to European Patent applications. For the patent applicants, this decision eases the burden of demonstrating the right to claim priority, while for the patent opponents, this raises the bar for challenging that priority claim during opposition proceeding. 

Particularly, the Enlarged Board held that:

  1. The EPO is competent to make determinations as to entitlement to priority;
  2. There is a rebuttable presumption that a party claiming priority is entitled to do so; and
  3. The rebuttable presumption applies even where the priority stems from an application (e.g., PCT) with non-identical applicants.

Previous case law from the Boards of Appeal at the EPO required that a party or parties claiming priority to a previously filed application when filing a European Patent Application must prove that the right to claim such priority was explicitly obtained prior to the filing date of the European Patent Application or its equivalent PCT.  See e.g., T577/11 and T1201/14.  In other words, an express assignment of the priority right was generally required, that assignment having been executed prior to filing of the European Application or equivalent.

In the present decision, the Enlarged Boards of Appeal has dismissed the past requirement in favour of a rebuttable presumption of entitlement to priority for applicants even where the applicants are not identical to the applicant(s) of the claimed priority. 

In coming to this conclusion, the Enlarged Board found that, “in the absence of substantial factual indications to the contrary, the joint filing of the subsequent PCT application sufficiently proves that the parties entered into an implied or informal agreement allowing [reliance] on the priority right.”  G2/22 at 136.  Although the Enlarged Board noted that “an agreement cannot be implied if not all of a plurality of priority applicants are applicants or co-applicants for the subsequent application…, the rebuttable presumption of priority entitlement can [still] be applied.” The Enlarged Board reasoned that in such circumstances, the missing priority applicant may be in a position to claim title of the subsequent application, or at a minimum, rebut the presumption of priority entitlement with sufficient evidence.  G2/22 at 137.

This decision is welcome news for proprietors facing priority challenges whether from their opponents or the EPO, as it eases the burden of demonstrating the right to claim priority. The rebuttable presumption may be of particular help in cases originating in the United States or other jurisdictions where ownership may not initially vest in the Applicant absent an express assignment, such as in cases where the priority application was filed in the name of the inventors while the application claiming priority was filed in the name of their employer.

Look for a more detailed analysis of this case and practice tips coming soon.

Tags

European Patent Office (EPO), EPO Guidelines

Related Practices

Appeals, Issues, and Legal Strategy

Patent Office Invalidation Proceedings

Patent Oppositions and Appeals

Prosecution and Portfolio Management

Patent Drafting and Prosecution

Related Offices

London

Contacts

James G. Bell
Partner
London
+44 (0)20 7864 2824
Email
Maeve O'Flynn
Partner
London
+44 (0)20 7864 2856
Email
Yelena Morozova
Partner
London
+44 (0)20 7864 2819
Email

Copyright © 2023 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information. 

Related Insights

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Webinar

Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement

May 18, 2026

Webinar

Articles

COPPA’s Amended Rule Is Now in Full Effect: What Operators Need to Know

May 15, 2026

Seminar

IP Strategy at the Crossroads: Technology, Enforcement, and Contracts

May 15, 2026

Taipei

Federal Circuit IP Blog

Federal Circuit Affirms § 102(b) Invalidity; Source Code Commands Are Not Hearsay

May 14, 2026

Webinar

Implementation of Long-Arm Jurisdiction by the UPC Court and German National Courts: Strategic Considerations and Practical Implications

May 12, 2026

Webinar

Workshop

Protecting Innovation in the Life Sciences: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law

May 7, 2026

Cambridge

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP